BIO? Great! But what about complex applications, such as healthcare? This article challenges whether the use of bioplastics in medical technology is reasonable and safe.
Plastics are established in medical technology. This is mainly due to the advantages of the material. Plastics have a low density and are therefore inexpensive for transport and storage. In addition, the established industrial manufacturing processes provide a great flexibility in form and application – both for disposable articles such as syringes and catheters as well as for e.g. endoscopes that are reprocessed several times. And thirdly, and this is very important today: prevention of infection. Contaminated products can be separated after their use in hospitals and then rendered harmless.
One could say that plastics made modern health care possible.
Today there are almost 8 billion people in the world, who are also getting older. In order to ensure health care , we need a large amount of resources. Most of the plastics used in medical technology are extracted from fossil resources. This is oviously not the best choice since on the one hand these resources are finite and on the other hand the whole process releases a large amount of CO2 . As a way out, there are biobased plastics that are made from renewable raw materials such as corn or sugar cane.
Yes, a change from conventional plastics to bioplastics is possible in medical technology whilst achieving the same performance: biocompatibility, adjustability of mechanical properties and sterilisability. Bioplastics can even bring decisive benefits.
By the way – plastics used in medical technology are called „Medical Grade Plastics“. For this, proof must be provided that the plastics have defined properties and that safe, approved raw materials are processed in a safe working environment. Similarly, the Medical Devices Regulation explicitly requires special attention to be paid to the selection of materials. This includes the biological assessment of materials, the risk management of procurement and production, and the guarantee of recipe consistency.
>> Plastic is an already established material
>> Es bietet eine Form- & Anwendungsflexibilität
>> Das Material eignet sich für Maßnahmen zur Keimvermeidung
>> Biokunststoff schont fossile Ressourcen
>> Biokunststoff hat einen geringerer CO2-Ausstoß (bis zu 85%)
Maria Heckel,
Regulation & Quality
“At BIOVOX, we take care of risk control from procurement through production and storage to the delivery of Medical Grade Bioplastics. We pay attention to the toxicological harmlessness during the development process by taking into account the intended purpose and risk class of the future medical device in the selection of materials. This ensures compatibility with other materials, tissues and body fluids. And not only that – the required cleanliness or even sterility are also covered.
Are you still unsure whether bioplastics are safe enough for your application? Please write to me about your requirements and concerns..“
Plastic as a material is indispensable in medical technology. To ensure the health of mankind in the future, we depend on the benefits of plastics. At the same time, we are facing a scarcity of resources and a climate crisis. Switching to biobased plastics saves resources and reduces the carbon footprint by up to 85%. And all of that with a constant performance and in compliance with strict safety regulations.
More BIOVOX knowledge
Solvent bonding allows thermoplastics to be bonded permanently without any heat source and without any adhesive remaining. In this short and more technical article, we look at how it works, suitable solvents and the advantages of this technique.
Medical devices account for almost a quarter of a hospital’s greenhouse gas emissions. How can we make them more sustainable?
Repackaged: What does the packaging of the future look like in the pharmaceutical industry?
Plastics are an indispensable part of the modern world. At the same time, we face the challenge of minimizing their ecological footprint and finding innovative solutions for the future. In this article, we look at the environmental impact, critical ingredients and the possibility of a climate-neutral circular economy based on renewable resources.
In this article, we look at how to generate value streams from hospital waste and recycle it into the production of new medical devices and pharmaceutical packaging. In short: how the circular economy succeeds in healthcare.
Your products are made from bioplastics now – great, but how do you communicate this switch to your target group? In this article, we explain how to communicate sustainability authentically.
BIOVOX 2025
